Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
CALT

Overview Financials Analysis Smart Money

Calliditas Therapeutics AB (publ)

CALT · NASDAQ

Analyze with AI

Filings1

Total reported value$0.0

Manager	Shares	Value	Change
Planning Capital Management Corp	0	$0.0	+100.0%

SymbolCALT

Market Cap$2.1B

IPO Date2020-06-05

CEORenee Aguiar-Lucander

Employees222

SectorHealthcare

IndustryBiotechnology

CountrySE

ExchangeNASDAQ Global Select

Luminar Technologies, Inc.

LAZR

$0.6044

+174.73%

NovaBay Pharmaceuticals, Inc.

NBY

$5.30

+79.66%

Mint Incorporation Limited

MIMI

$0.4795

+75.45%

Autozi Internet Technology (Global) Ltd.

AZI

$2.50

+64.47%

GD Culture Group Limited

GDC

$5.26

+51.59%

Peers

DICE Therapeutics, Inc.

DICE · NASDAQ

$47.55

+0.06%

Longboard Pharmaceuticals, Inc.

LBPH · NASDAQ

$59.98

0.00%

BELLUS Health Inc.

BLU · NASDAQ

$14.75

+0.03%

Provention Bio, Inc.

PRVB · NASDAQ

$24.98

+0.00%

Fusion Pharmaceuticals Inc.

FUSN · NASDAQ

$21.55

+0.14%

Myovant Sciences Ltd.

MYOV · NYSE

$26.98

-0.04%

Chinook Therapeutics, Inc.

KDNY · NASDAQ

$40.39

+0.22%

Deciphera Pharmaceuticals, Inc.

DCPH · NASDAQ

$25.59

+0.08%

Ambrx Biopharma Inc.

AMAM · NYSE

$28.00

+0.07%

Morphic Holding, Inc.

MORF · NASDAQ

$56.99

+0.04%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.